KRT18 and neoplasm: Exceptional responders to therapy exhibit increased RNA abundance of KRT8 and KRT18 relative to nonresponders to therapy (Extended Data Fig. 10a,b), consistent with exceptional responders to therapy having tumours with luminal features.